Host genetic variation in ICAM-1 can lead to altered disease susceptibility and clinical outcome, including variant ICAM-1Kilifi which is associated with higher or sometimes in contradiction, decreased susceptibility to cerebral malaria in different geographical regions. Here, ICAM1 is linked to cerebral malaria.